7 completed, 2 unknown, 1 recruiting, 1 terminated. 4 Not applicable, 4 Phase 2, 3 Phase 3, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Unknown 1, Withdrawn 1 |
| Phase 2 | 4 | Completed 2, Recruiting 1, Terminated 1 |
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow MP: new trials by email Literature Review of MP trials Research Report on MP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients Telitacicept, Hydroxychloroquine, Prednisone - Systemic Lupus Erythematosus | Phase 4 | Unknown | Fen Li | 30 | 2022-12-31 | 2024-01-17 |
| A Digital Approach to Improving Carbohydrate Periodisation Behaviours in Athlete: SMART+ Study MP, Call, MesC - Diet Habit | Not applicable | Unknown | Liverpool John Moores University | 1000 | 2020-09-14 | 2020-11-27 |
| Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY) (Plan 1), Fludarabine (FLU) - Fanconi Anemia, Severe Aplastic Anemia | Phase 2 | Recruiting | Masonic Cancer Center, University of Minnesota | 48 | 2018-11-13 | 2026-01-30 |
| Mental Practice Versus Proprioceptive Neuromuscular Facilitation on Strength of Upper Limb mental practice, proprioceptive neuromuscular facilitation - Motor Activity | Not applicable | Withdrawn | Wafaa Mahmoud Amin | 2018-05-08 | 2019-05-17 | |
| Osteopathic Manipulative Treatment Induces Functional Connectivity Changes OMT, MP - Osteopathic Manipulative Treatment | Not applicable | Completed | I.R.C.C.S. Fondazione Santa Lucia | 30 | 2017-09-30 | 2020-05-14 |
| Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia vincristine sulfate, prednisone, doxorubicin hydrochloride - B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia | Phase 3 | Completed | Children's Oncology Group | 275 | 2007-03-01 | 2024-03-26 |
| Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia alemtuzumab, asparaginase, methotrexate - Recurrent Adult Acute Lymphoblastic Leukemia | Phase 2 | Terminated | National Cancer Institute (NCI) | 12 | 2006-06-01 | 2015-05-05 |
| Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia alemtuzumab, methotrexate, mercaptopurine - Recurrent Childhood Acute Lymphoblastic Leukemia | Phase 2 | Completed | National Cancer Institute (NCI) | 25 | 2004-07-01 | 2013-06-05 |
| Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia filgrastim, asparaginase, cyclophosphamide - Childhood Acute Lymphoblastic Leukemia in Remission, Recurrent Childhood Acute Lymphoblastic Leukemia | Phase 3 | Completed | National Cancer Institute (NCI) | 220 | 2002-10-01 | 2014-02-27 |
| Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia prednisone, vincristine sulfate, daunorubicin hydrochloride - T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia | Not applicable | Completed | National Cancer Institute (NCI) | 100 | 2001-04-01 | 2013-01-16 |
| Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia Anti-Thymocyte Globulin, Cyclophosphamide, Fludarabine - Fanconi Anemia | Phase 1 / Phase 2 | Completed | Masonic Cancer Center, University of Minnesota | 31 | 2000-02-17 | 2021-10-12 |
| Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia tretinoin, daunorubicin hydrochloride, cytarabine - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Promyelocytic Leukemia (M3) | Phase 3 | Completed | National Cancer Institute (NCI) | 420 | 1999-06-01 | 2013-06-05 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Fanconi Anemia (2) · Anemia, Aplastic (1) · Bone Marrow Failure Disorders (1) · Dyskeratosis Congenita (1) · Feeding Behavior (1) · Leukemia, Promyelocytic, Acute (1) · Lupus Erythematosus, Systemic (1) · Motor Activity (1) · Myelodysplastic Syndromes (1)
National Cancer Institute (NCI) (5) · Masonic Cancer Center, University of Minnesota (2) · Children's Oncology Group (1) · Fen Li (1) · I.R.C.C.S. Fondazione Santa Lucia (1) · Liverpool John Moores University (1) · Wafaa Mahmoud Amin (1)
United States (8) · Australia (1) · Canada (1) · China (1) · Italy (1) · Saudi Arabia (1) · Switzerland (1) · United Kingdom (1)
Anne Angiolillo (1) · Bayard Powell (1) · Fen Li, doctor (1) · Glen Lew, MD (1) · Kimberly Dunsmore (1) · Kirk Schultz (1) · Margaret L. MacMillan, MD (1) · Margaret MacMillan, MD, Msc, FRCPC (1) · Peter Wiernik (1)
PMID 20705755, PMID 32001530, PMID 33242441
U10CA098543 (3), U01CA097452 (1), U10CA021115 (1), U10CA031946 (1)